Q2 2026 Tenet Healthcare Corp Earnings Call Transcript
Key Points
- Tenet Healthcare Corp (THC) reported strong financial performance with second quarter net operating revenues of $5.6 billion and consolidated adjusted EBITDA of $1.304 billion, representing a 16.3% growth over the prior year.
- The company increased its full-year 2026 guidance for revenue, adjusted EBITDA, and cash flow, reflecting optimism about continued growth.
- USPI, a segment of THC, generated $542 million in adjusted EBITDA, marking a 9% growth over the second quarter of 2025, with a robust pipeline of partnerships.
- THC's hospital segment reported a 22% growth in adjusted EBITDA, driven by strong volume growth and disciplined expense management.
- The company has been active in share repurchases, buying back 7 million shares in the first half of 2026, and the Board authorized a $2 billion increase in the share repurchase program, indicating confidence in the company's strategy.
- Exchange revenues declined by 17% compared to the second quarter of 2025, with significant impacts in states like Florida, Arizona, Michigan, South Carolina, and Texas.
- The decline in exchange enrollment presents challenges, leading to a $65 million revenue headwind in the second quarter.
- Same-facility case volumes in USPI were down 1.2%, reflecting a focus on higher acuity procedures but indicating some volume weakness.
- The company faces industry headwinds, including payer mix shifts and insurance enrollment uncertainty in exchanges and Medicaid.
- There is a potential impact from the proposed changes in the outpatient rule and 340B reallocation, which could affect future financial performance.
Welcome to Tenet Healthcare second quarter 2026 earnings conference call. After the speaker's remarks, there will be a question-and-answer session for industry analysts. (Operator Instructions)
I'll now turn the call over to your host, Mr. Will McDowell. Vice President of Investor Relations. Mr. McDowell, you may begin.
Good morning, everyone, and thank you for joining today's call. I am Will McDowell, Vice President of Investor Relations. We're pleased to have you join us for a discussion of Tenet's second quarter 2026 results as well as a discussion of our financial outlook. Tenant senior management participating in today's call will be Dr. Sam Sutaria, Chairman and Chief Executive Officer; and Sun Park, Executive Vice President and Chief Financial Officer. Our webcast this morning includes a slide presentation, which has been posted to the Investor Relations section of our website, tenethealth.com.
Listeners to this call are advised that certain statements made
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
